Steroid

Welcome to another edition of CEDARS/ASPENS Debates. CEDARS/ASPENS is a society of cornea, cataract and refractive surgery specialists, here to discuss some of the latest hot topics in ophthalmology.

SAN DIEGO — Patients with severe asthma required fewer steroid bursts with tezepelumab-ekko, according to a poster presented at the 2025 American Academy of Allergy, Asthma & Immunology/World Allergy Organization Joint Congress.

MIAMI BEACH, Fla. — Topical steroid withdrawal syndrome may signal a reminder to clinicians to be good stewards of topical treatments, according to a speaker at Masters of Pediatric Dermatology.

BOSTON — The use of biologics to treat asthma during pregnancy “is very likely safe,” but the choice should follow shared decision-making, S. Shahzad Mustafa, MD, said during his presentation at the CHEST Annual Meeting.

WASHINGTON —Micaela F. Bayard, MD, spoke with Healio about the management of steroids and how this topic was covered at ACR Convergence 2024.

Inflammation is associated with every surgical procedure.

Inflammation is a common but treatable complication of cataract surgery.

BOSTON — Symptoms improved with mepolizumab after treatment with omalizumab failed for a patient with asthma who developed allergic bronchopulmonary aspergillosis, according to a poster presented at the CHEST Annual Meeting.

The FDA has approved Palforzia, an oral immunotherapy designed to protect children aged 1 to 3 years with peanut allergies from reactions caused by accidental exposure, according to a press release.

Higher levels of urinary adrenal steroid metabolites during infancy were associated with lower odds for asthma at age 5 years, according to a study published in Annals of Allergy, Asthma & Immunology.